Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Helix TCS (OTC: HLIX) CEO Zachary Venegas talks cannabis industry M&A in technology and security services. Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over […]
[restrict paid=”true”] Plus Products, Inc. (OTC: PLPRF) (CSE: PLUS) Interview with CEO Jake Heimark, discussing the company’s branded cannabis edibles, which are driving revenue growth that increased […]
PLAYA VISTA, May 09, 2019 – American Premium Water Corporation (OTC: HIPH) CEO Ryan Fishoff provides an update to shareholders on the Company’s progress in the 1 quarter and outlook for the rest of the year. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
